Optogenetic control of NOTCH1 signaling

Joanna Kałafut1, Jakub Czapiński1, Alicja Przybyszewska-Podstawka1

  • 1Department of Biochemistry and Molecular Biology, Medical University of Lublin, 21-093, Lublin, Poland.

Insights

Scientists developed optoNotch, a light-activated system to control NOTCH1 signaling. This tool precisely regulates Notch signaling in breast cancer cells, revealing its role in proliferation, migration, and chemoresistance.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • The Notch signaling pathway regulates cell differentiation and tissue organization.
  • Deregulation of Notch signaling is implicated in various diseases, including breast cancer.
  • NOTCH1 promotes breast cancer progression by enhancing proliferation and cancer stem cell maintenance.

Purpose of the Study:

  • To develop a light-inducible system (optoNotch) for precise control of NOTCH1 signaling.
  • To investigate the role of NOTCH1 activation in breast cancer cell behavior and drug resistance.
  • To understand the spatiotemporal dynamics of Notch signaling in cancer.

Main Methods:

  • Engineering of an optogenetic NOTCH1 receptor (optoNotch).
  • Activation of optoNotch using light to control Notch intracellular domain (N1ICD) activity.
  • Assessment of NOTCH1 effects on cell proliferation, migration, and chemoresistance in MCF7 and MDA-MB-468 cells using 2D and 3D cultures.

Main Results:

  • OptoNotch successfully enabled light-controlled, ligand-independent activation of N1ICD.
  • NOTCH1 activation significantly increased proliferation in breast cancer cells.
  • Distinct cell-type specific migratory phenotypes and induced chemoresistance were observed upon optoNotch activation.

Conclusions:

  • OptoNotch provides a powerful tool for fine-tuning N1ICD activity with spatiotemporal control.
  • This system enhances the understanding of Notch signaling complexity in breast cancer.
  • OptoNotch activation contributes to increased proliferation, altered migration, and chemoresistance in breast cancer cells.